Potential impact of socioeconomic differences on clinical outcomes in international clinical trials

American Heart Journal

Volumn 141, Issue 6, 2001, Pages 1019-1024

  Shibata, Marcelo C ^a,e   Flather, Marcus D ^a,b   De Arenaza, Diego Perez ^a   Wang, Duolao ^c   Conor O'Shea, J ^d  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; EPTIFIBATIDE; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTERY BYPASS; BODY MASS; CLINICAL TRIAL; CONFERENCE PAPER; DEATH; HEART CATHETERIZATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; MORBIDITY; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; SOCIOECONOMICS; UNSTABLE ANGINA PECTORIS;

EID: 0035371573     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.115529     Document Type: Conference Paper

References (20)

1. Fox KA, Goodman S, Bigonzi F, et al. Inter-regional differences and outcome in unstable angina: analysis of the international ESSENCE trial. Eur Heart J 2000;21:1433-9.
2. Akkerhuis KM, Deckers JW, Boersma E, et al. Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. Eur Heart J 2000;21:371-81.
3. Yusuf S, Flather M, Pogue J, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) registry investigators. Lancet 1998;15; 352:507-14.
4. Faergeman O, Kjekshus J, Cook T, et al. Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S). Eur Heart J 1998; 19:1531-7.
5. Eisenberg MJ, Califf RM, Cohen EA, et al. Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada: Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-1) and Canadian Coronary Atherectomy Trial (CCAT) investigators. Am J Cardiol 1997;79:867-72.
6. Hebert PR, Rich-Edwards JW, Manson JE, et al. Height and incidence of cardiovascular disease in male physicians. Circulation 1993;88:1437-43.
7. Liao Y, McGee DL, Cao G, et al. Short stature and risk of mortality and cardiovascular disease: negative findings from the NHANES I epidemiologic follow-up study. J Am Coll Cardiol 1996;27:678-82.
8. Yarnell JW, Limb ES, Layzell JM, et al. Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies. Eur Heart J 1992;13:1602-5.
9. Wamala SP, Mittleman MA, Horsten M, et al. Short stature and prognosis of coronary heart disease in women. J Intern Med 1999; 245:557-63.
10. D'Avanzo B, La Vecchia C, Negri E. Height and the risk of acute myocardial infarction in Italian women. Soc Sci Med 1994;38:193-6.
11. Jousilahti P, Tuomilehto J, Vartiainen E, et al. Relation of adult height to cause-specific and total mortality: a prospective follow-up study of 31, 199 middle-aged men and women in Finland. Am J Epidemiol 2000;151:1112-20.
12. Granger CB, Stebbins A, White H, et al. Short stature is associated with higher mortality after acute Ml: observation from the GUSTO trial [abstract]. Circulation 1994;90(Suppl):1110.
13. Comoni-Huntley JG, Harris TB, Everett DF, et al. An overview of body weight of older patients, including the impact on mortality: The National Health and Nutrition Examination Survey I-Epidemiologic Follow-up Study. J Clin Epidemiol 1991;44:743-53.
14. Diehr P, Bild DE, Harris TB, et al. Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study. Am J Public Health 1998;88:623-9.
15. Durazo-Arvizu R, Cooper RS, Luke A, et al. Relative weight and mortality in US blacks and whites: findings from representative national population samples. Ann Epidemiol 1997;7:383-95.
16. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995;333:677-85.
17. Lee IM, Manson JE, Hennekens CH, et al. Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA 1993;15;270: 2823-8.
18. Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338:1-7.
19. Calle EE, Thun MJ, Petrelli JM, et al. Body mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999;341: 1097-105.
20. Salomaa V, Niemela M, Miettinen H, et al. Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation 2000;101:1913-8.